Intrinsiqs

Is Viridian Therapeutics, Inc. overvalued?

Viridian Therapeutics, Inc. (VRDN) — key valuation metrics and fundamentals.

No verdict
Price
$18.82
Fair value
Current P/E
Normal P/E
Market cap
$1.68B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares VRDN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.